Investigation of the genetic influence of the OPG, VDR (Fok1), and COLIA1 Sp1 polymorphisms on BMD in the Irish population.
Low bone mineral density (BMD) is a major risk factor for the development of osteoporosis and there is strong evidence to suggest that the procurement and preservation of peak BMD is genetically determined. In an effort to identify factors responsible for susceptibility to low BMD in the Irish population, we investigated its possible association with polymorphisms in the Osteoprotegerin (OPG) gene, Type I collagen alpha 1 (COLIA1) Sp1 binding site and vitamin D receptor (VDR) start codon. Following a systematic screening of the regulatory and coding regions of the OPG gene, we identified a novel G1181C polymorphism in exon 1 and a T950C polymorphism in the promoter region of the OPG gene. Participants were recruited from the Bone Densitometry Unit of Cork University Hospital, including 381 postmenopausal women aged 61.26 +/- 8.50 (mean +/- SD) and 130 premenopausal women aged 46.30 +/- 6.50 (mean +/- SD). Following association analysis using both the premenopausal and postmenopausal cohorts we found that postmenopausal women carrying one or more C alleles of the G1181C polymorphism had 14.8% lower BMD (P = 0.05) at the lumbar spine and 14.4% lower BMD (P = 0.04) at the FN. However, both were nonsignificant when the Bonferroni correction factor (0.01 significance level) was applied to correct for multiple hypothesis testing. We found no association between alleles of the T950C OPG polymorphism and BMD. Similarly, we have found a lack of association between the VDR (fok1) polymorphism or COLIA1 Sp1 polymorphism and low BMD in either postmenopausal or premenopausal women in this population.
Wynne
F
F
Departments of Rheumatology, University College, Cork, Ireland.
Drummond
F
F
O'Sullivan
K
K
Daly
M
M
Shanahan
F
F
Molloy
M G
MG
Quane
K A
KA
D001483:Base Sequence; D001827:Body Height; D001835:Body Weight; D015519:Bone Density / Q000502:physiology*; D018387:Codon, Initiator / Q000235:genetics; D024042:Collagen Type I / Q000235:genetics*; D017931:DNA Primers; D005260:Female; D006023:Glycoproteins / Q000235:genetics*; D006801:Humans; D007494:Ireland; D008403:Mass Screening; D008593:Menopause; D008875:Middle Aged; D053244:Osteoprotegerin; D011110:Polymorphism, Genetic; D020641:Polymorphism, Single Nucleotide; D017698:Postmenopause; D017697:Premenopause; D011401:Promoter Regions, Genetic; D018167:Receptors, Calcitriol / Q000235:genetics*; D018160:Receptors, Cytoplasmic and Nuclear / Q000235:genetics*; D018124:Receptors, Tumor Necrosis Factor; D012189:Retrospective Studies
D018387:Codon, Initiator; D024042:Collagen Type I; D017931:DNA Primers; D006023:Glycoproteins; D053244:Osteoprotegerin; D018167:Receptors, Calcitriol; D018160:Receptors, Cytoplasmic and Nuclear; D018124:Receptors, Tumor Necrosis Factor; C506030:TNFRSF11B protein, human